Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT)
暂无分享,去创建一个
[1] T. Warkentin. Vaccine-induced immune thrombotic thrombocytopenia (VITT) , 2022, Seminars in Hematology.
[2] J. Curnow,et al. Australian and New Zealand approach to diagnosis and management of vaccine‐induced immune thrombosis and thrombocytopenia , 2021, The Medical journal of Australia.
[3] M. Pai,et al. Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination , 2021, Thrombosis and Haemostasis.
[4] G. Ambler,et al. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis , 2021, The New England journal of medicine.
[5] G. Lippi,et al. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. , 2021, JAMA cardiology.
[6] J. Kelton,et al. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia , 2021, Nature.
[7] M. Dimopoulos,et al. High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events , 2021, Vaccines.
[8] S. Noronha,et al. Thrombosis With Thrombocytopenia After the Messenger RNA–1273 Vaccine , 2021, Annals of Internal Medicine.
[9] A. Cuker,et al. Thrombosis After Vaccination With Messenger RNA–1273: Is This Vaccine-Induced Thrombosis and Thrombocytopenia or Thrombosis With Thrombocytopenia Syndrome? , 2021, Annals of Internal Medicine.
[10] E. Favaloro. Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia , 2021, International journal of laboratory hematology.
[11] P. Choi. Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. , 2021, The New England journal of medicine.
[12] S. Ting,et al. The first known case of vaccine‐induced thrombotic thrombocytopenia in Australia , 2021, The Medical journal of Australia.
[13] S. de Lusignan,et al. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland , 2021, Nature Medicine.
[14] J. Kelton,et al. Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia , 2021, The New England journal of medicine.
[15] M. Makris,et al. Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT) , 2021, Research and Practice in Thrombosis and Haemostasis.
[16] S. Susen,et al. PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia , 2021, The New England journal of medicine.
[17] A. Greinacher,et al. Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2 , 2021, Blood.
[18] J. Oldenburg,et al. Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH , 2021, Hämostaseologie.
[19] M. Schull,et al. Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID-19 Vaccination: Lay Summary , 2021 .
[20] E. Woo,et al. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021. , 2021, JAMA.
[21] Anna Eriksson,et al. An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination , 2021, Journal of Thrombosis and Haemostasis.
[22] D. Goldblatt,et al. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination , 2021, The New England journal of medicine.
[23] G. Tiscia,et al. Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET). , 2021, Blood transfusion = Trasfusione del sangue.
[24] S. Koepsell,et al. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination , 2021, The New England journal of medicine.
[25] Fridtjof Lund-Johansen,et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination , 2021, The New England journal of medicine.
[26] J. Oldenburg,et al. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH , 2021, Hämostaseologie.
[27] S. Eichinger,et al. A Prothrombotic Thrombocytopenic Disorder Resembling Heparin-Induced Thrombocytopenia Following Coronavirus-19 Vaccination , 2021 .
[28] E. Favaloro,et al. Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment , 2021, Expert review of hematology.
[29] C. Demirdover. COVID-19-vaccines , 2021, Reactions Weekly.
[30] E. Duncan,et al. A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia. , 2020, Pathology (Sydney).
[31] E. Favaloro,et al. Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update. , 2017, Pathology.
[32] K. Chalkidou. About the National Institute for Health and Care Excellence - NICE. , 2013, Acta medica portuguesa.
[33] J. R. Scotti,et al. Available From , 1973 .